Sort
39,280 grants matching “leukemia”
Is Stroke a Late Effect of Chemotherapy?
$321,869Ann M. Geiger · Wake Forest University Health Sciences · R01 · FY2006 · CA
Mechanisms of Splice Site Selection in Health and Disease
$321,856Shalini Sharma · University Of Arizona · R01 · FY2020 · GM
Signal Transduction by Non-transmembrane PTPs
$321,845Benjamin G. Neel · University Health Network · R37 · FY2008 · CA
KillerRed Assisted Mutagenesis to discover cancer drug resistance genes
$321,833Daniel G. Jay · Tufts University Boston · R01 · FY2013 · CA
Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
$321,833Bryan R. Cullen · Duke University · R01 · FY2019 · DA
ANTITUMOR ANTIBIOTICS FROM MARINE ORGANISMS
$321,827University Of California San Diego · R01 · FY2003 · CA
Enhancing CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor
$321,825Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2024 · CA
Adenosine Analogs: Therapeutics for Hematologic Cancers
$321,801Steven Terry Rosen · Northwestern University At Chicago · R01 · FY2006 · CA
Genomics of AML Relapse
$321,797John F Dipersio · Washington University · P01 · FY2014 · CA
MOUSE MODELS FOR FAMILIAL PLATELET DISORDER
$321,769Dartmouth College · R01 · FY2002 · CA
CO-FACILITATORS: NOVEL REGULATORS OF HORMONE METABOLISM
$321,765Cedars-Sinai Medical Center · R01 · FY2002 · DK
Haploidentical Allogeneic Transplantation
$321,692Baylor College Of Medicine · R21 · FY2001 · CA
Kinase Target of Diverse Cell Surface Receptors in Cancer Invasion and Metastasis
$321,646Ann Marie Pendergast · Duke University · R01 · FY2012 · CA
Foamy Virus Vectors for Stem Cells
$321,630David W Russell · University Of Washington · P01 · FY2006 · HL
Therapeutic Mechanisms in Chronic Myelogenous Leukemia
$321,625Whitehead Institute For Biomedical Res · R01 · FY2002 · CA
Exploiting Metabloic Defects in Tumors with Mutant IDH1 and IDH2
$321,625Christian Michael Metallo · University Of California, San Diego · R01 · FY2018 · CA
Berberine downregulates MDM2 by interaction with DAXX in cancer cells
$321,625Muxiang Zhou · Emory University · R01 · FY2010 · CA
Development of a dual small-molecule BCl-XL/BCL-2 inhibitor for non-small cell lu
$321,625Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Exploiting Metabloic Defects in Tumors with Mutant IDH1 and IDH2
$321,625Christian Michael Metallo · University Of California, San Diego · R01 · FY2014 · CA
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
$321,625Bruno Calabretta · Thomas Jefferson University · R01 · FY2013 · CA
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
$321,625Bruno Calabretta · Thomas Jefferson University · R01 · FY2015 · CA
Development of a dual small-molecule BCl-XL/BCL-2 inhibitor for non-small cell lu
$321,625Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
$321,625Bruno Calabretta · Thomas Jefferson University · R01 · FY2017 · CA
Development of a dual small-molecule BCl-XL/BCL-2 inhibitor for non-small cell lu
$321,625Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Development of a dual small-molecule BCl-XL/BCL-2 inhibitor for non-small cell lu
$321,625Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2015 · CA